Circulating Endothelium Progenitor Cells and Endogenous Oestrogen in Healthy Subjects
NCT ID: NCT00668252
Last Updated: 2008-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2006-04-30
2007-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recruitment and course of the study: The subjects will be recruited among the CIC's pool of healthy volunteers. Volunteer people will then have biological and clinical baseline examinations. If they match the inclusion criteria, an appointment will be taken for the blood sample intend for the characterization of the EPC and hormonal plasma levels evaluation. The participation will not exceed 2 months. Young women will have to come between the 9th and the 11th day after the beginning of menses). A total of 150 ml of peripheral blood will be collected. The study will last 18 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Non menopausal women
No interventions assigned to this group
2
age matched men
No interventions assigned to this group
3
Menopausal women
No interventions assigned to this group
4
age matched men
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non menopausal women :
* age 18 to 40 years,
* regular menstrual cycles
* no hormone therapy as contraceptives
* postmenopausal women :
* age above 55 years old
* amenorrhoea since 5 years at least
* no hormone therapy since at least 3 month
Exclusion Criteria
* inclusion in another study
* smoking, Statins treatment, uncontrolled diabetes or hypertension and personal history of cardiovascular disease.
18 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department Clinical Research of Developpement
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tabassome Simon, MD - PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique Hopitaux de Paris - Université Pierre et Marie Curie Paris 6
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Hopitaux de Paris - Hopital Saint Antoine
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P050904
Identifier Type: -
Identifier Source: org_study_id